BMO downgrades Amgen to Market Perform from Outperform
BMO Capital downgraded Amgen to Market Perform from Outperform, according to Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.